Table I.
Clinicopathological characteristics | Total | High expression | Low expression | χ2 | P-value |
---|---|---|---|---|---|
Sex | |||||
Male | 24 | 11 | 13 | 0.06341 | 0.8012 |
Female | 46 | 24 | 22 | ||
Age, years | |||||
≤60 | 37 | 20 | 17 | 0.2293 | 0.632 |
>60 | 33 | 15 | 18 | ||
Tumor size | |||||
T1 | 17 | 14 | 3 | 16.33 | 0.001 |
T2 | 15 | 10 | 5 | ||
T3 | 16 | 6 | 10 | ||
T4 | 22 | 5 | 17 | ||
Distant metastasis | |||||
Positive | 33 | 13 | 20 | 12.87 | 0.0003 |
Negative | 37 | 22 | 15 | ||
Differentiation | |||||
High | 26 | 6 | 20 | 17.37 | 0.0002 |
Moderate | 21 | 10 | 11 | ||
Poor | 23 | 19 | 4 | ||
Lymph node metastasis | |||||
Positive | 38 | 6 | 26 | 20.78 | <0.0001 |
Negative | 32 | 29 | 9 | ||
TNM stages | |||||
I | 19 | 15 | 4 | 11.8 | 0.0081 |
II | 14 | 8 | 6 | ||
III | 15 | 6 | 9 | ||
IV | 22 | 6 | 16 |
Data were analyzed using a χ2 test.